UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045898
Receipt number R000052397
Scientific Title Effectiveness of radical stereotactic body radiotherapy for vertebral bone metastasis
Date of disclosure of the study information 2021/10/29
Last modified on 2021/10/28 14:01:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of radical stereotactic body radiotherapy for vertebral bone metastasis

Acronym

SBRT for vertebral bone metastasis

Scientific Title

Effectiveness of radical stereotactic body radiotherapy for vertebral bone metastasis

Scientific Title:Acronym

SBRT for vertebral bone metastasis

Region

Japan


Condition

Condition

The patients with vertebral bone metastasis

Classification by specialty

Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Investigation of the effectiveness of radiation therapy for spinal metastases. Local control time and overall survival.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Local control time and overall survival.

Key secondary outcomes

EORTC Grade 3 or higher appearance frequency


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Effectiveness when irradiating 30 Gy using SBRT

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who do not meet the exclusion criteria

Key exclusion criteria

Primary lesion is not controlled
Metastases to other sites
Life prognosis within 1 month
I can't communicate
Radiation therapy cannot be planned depending on the site of cancer

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Osamu
Middle name
Last name Tanaka

Organization

Asahi University Hospital

Division name

Radiation Oncology

Zip code

5008523

Address

3-23 Hashimoto-cho, Gifu city, Gifu

TEL

0582538001

Email

c.bluered@gmail.com


Public contact

Name of contact person

1st name Osamu
Middle name
Last name Tanaka

Organization

Asahi University Hospital

Division name

Radiation Oncology

Zip code

5008523

Address

3-23 Hashimoto-cho, Gifu city, Gifu

TEL

0583747635

Homepage URL


Email

c.bluered@gmail.com


Sponsor or person

Institute

Asahi University

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Asahi University Hospital

Address

3-23 Hashimoto-cho, Gifu city, Gifu

Tel

0582538001

Email

c.bluered@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2021 Year 10 Month 28 Day

Date of IRB


Anticipated trial start date

2021 Year 11 Month 08 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 10 Month 28 Day

Last modified on

2021 Year 10 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052397